Startup Atlas
bighatbio.com
BigHat Biosciences develops AI-designed therapeutics and an agentic data platform for protein design.
Last successful source check: 2026-10-26
Company website: bighatbio.com
Inclusion criteria were assessed against available sources. Private-company status and category may be model assessments; no hands-on test or independent confirmation is implied.
- Status
- Unknown or unverified
- Category
- Unknown or unverified
- Validated funding
- $75 million Series C · announced date not found
- Pricing excerpt
- Unknown or unverified
- Open roles
- Unknown or unverified
- AI visibility
- Unmeasured. Visibility products are held.
What it does
Eli Lilly announced NanoLab, a VHH developability model built on data generated by BigHat's Milliner platform. Source
What the company says (captured excerpt)
BigHat Biosciences Better therapeutics for patients Discover more News Eli Lilly and Company (Lilly) announced the release of their TuneLab VHH developability model called NanoLab built on robust data generated by BigHat's Milliner™ platform BigHat Biosciences Announces $75 Million Series C Financing to Advance AI-Designed Therapeutics and Leading Agentic Data Platform for Rapid Protein Design BigHat Biosciences An
Captured company wording; it may be incomplete. No hands-on test is implied.
Identity & inclusion
Name: Unknown or unverified; last successful source check 2026-10-26
Legal name: Unknown or unverified; last successful source check 2026-10-26
Privately held: Yes · Model assessment
Founded: Unknown or unverified; last successful source check 2026-10-26
Pricing
Unknown or unverified; last successful source check 2026-10-26
Validated price change history is unavailable in this snapshot.
How it differs
Model comparison is unmeasured; no checked comparison with five nearest rivals is available in this snapshot.
Launches and changes
Validated product launch and change history is unavailable in this snapshot.
Team signals
Open roles: Unknown in this snapshot.
Departments are unavailable in this snapshot.
Similar startups
Validated similar startups are unavailable in this snapshot.
Funding & backers
$75 million Series C · announced date not found
- $75 million Series C · announced date not found · Source
Offering amendments are combined. Announcement and filing overlap is unresolved, so these rows are not added into a total raised.
Unknown or unverified; last successful source check 2026-10-26
Sources & check dates
Checked 2026-10-26
SHA-256 7f63cbe977540b8c4ba91d486a3a44d352ccaaff9d93491629a1cc58ed269c3cBigHat Biosciences Better therapeutics for patients Discover more News Eli Lilly and Company (Lilly) announced the release of their TuneLab VHH developability model called NanoLab built on robust data generated by BigHat's Milliner™ platform BigHat Biosciences Announces $75 Million Series C Financing to Advance AI-Designed Therapeutics and Leading Agentic Data Platform for Rapid Protein Design BigHat Biosciences An
Checked 2026-10-26
SHA-256 b31649936d2d60fbae88ac83214bc939aeaf0209ff36667dc0c94e89ef8b3c2b$75 million